<DOC>
	<DOCNO>NCT01106859</DOCNO>
	<brief_summary>A study healthy volunteer next morning drive performance middle-of-the-night dose 3.5 mg zolpidem tartrate sublingual tablet , sleep aid . The next morning drive performance measure take standardized drive test .</brief_summary>
	<brief_title>Driving Performance After Middle Night Administration 3.5 mg Zolpidem Tartrate Sublingual Tablet</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<mesh_term>Zopiclone</mesh_term>
	<criteria>Male female subject age 21 64 inclusive . For female subject : Female subject include postmenopausal sterilize , childbearing potential , breastfeeding , pregnancy test negative , intention become pregnant course study , use adequate contraceptive drug device . Medically acceptable method contraception may use subject and/or partner : oral contraceptive , progestin injection implant , condom spermicide , diaphragm spermicide , IUD , vaginal spermicidal suppository , surgical sterilization abstinence . Females use oral contraception must start use medication least 4 week prior screen . Surgical sterilization must occur least 6 week prior screen . Good health basis prestudy history physical examination , vital sign result blood chemistry , hematology , urinalysis Good binocular visual acuity , correct uncorrected Possession valid driver 's license 3 year Driving experience least 3000 km/year Signed informed consent A history drug addiction drug substance abuse , include alcohol abuse , within past 12 month Has history restless legs syndrome , sleep apnea , narcolepsy primary sleep disorder A know hypersensitivity zolpidem zopiclone Has undergone oral surgery , tooth extraction pierce lip/tongue within 60 day prior screen Has use medication promote sleep , include herbal medication , within 14 day ( 5 halflives drug , whichever long ) prior screen Prescription medication health condition allow long subject stable dose least 30 day prior screen Has take drug know induce hepatic drug metabolism ( i.e. , rifampin ) within 30 day prior screen BMI &gt; 29 Kg/M^2 Current use medication affect drive performance Smokes 10 cigarettes/day Uses tobacco product period nighttime awaken Consumes 6 cup coffee/day Consumes 21 glass alcohol/week Has receive investigational drug within 60 day 5 halflives ( whichever longer ) prior screen Has additional condition ( ) Investigator 's opinion would : Affect sleep/wake function Prohibit subject complete study Not best interest subject participate study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>insomnia</keyword>
</DOC>